Science
Mechanism of Action
This sophisticated fusion peptide is theorized to exert its effects through several key biological pathways. As a skin conditioning and protecting agent, it contributes to overall skin health and offers antioxidant benefits. The SH-Oligopeptide-2 component, structurally analogous to Insulin-like Growth Factor 1 (IGF-1), is believed to stimulate cellular regeneration and accelerate natural wound healing processes. Furthermore, it is suggested to enhance the biosynthesis of critical extracellular matrix components, including hyaluronic acid and collagen, which are vital for maintaining skin plumpness and structural integrity. By improving skin cell communication, this peptide is expected to lead to a smoother skin texture and a reduction in the appearance of fine lines and wrinkles.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Safety
Safety Profile
Specific safety assessments from regulatory bodies such as CIR, SCCS, or FDA for this precise fusion peptide are currently unavailable. While broad discussions exist for other peptides, this exact ingredient lacks dedicated review. It's noted that related growth factors, such as SH-Oligopeptide-1, have been associated with potential allergic reactions. Additionally, there are general concerns regarding growth factors due to their capacity to stimulate cell proliferation, which could be a consideration if pre-existing cancerous cells are present.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While its proposed mechanism suggests promising benefits for skin regeneration and anti-aging, the absence of specific clinical studies and comprehensive safety reviews for this exact fusion peptide indicates insufficient data for a definitive endorsement.
Related
Similar Ingredients
Finding similar ingredients…